Reducing LDL-C and Cardiovascular Risk with Nonstatin Therapy: From Evidence to Practice
July 02, 2019
In this symposium, lipid experts Dr. Robert Giugliano, Dr. Marc Sabatine, and Dr. James Underberg will describe best practices for internists in managing LDL-C and reducing the risk for major cardiovascular events with the addition of nonstatin therapy.
CME 2.00 Credits
LDL-Cholesterol Lowering and Atherosclerotic Cardiovascular Disease Risk Reduction: Exploring the Evidence With Non-Statin Therapy
June 17, 2018
n this program, lipid experts will present, in state-of-the-art lectures and in 'realworld' interactive cases, optimal strategies and provide 'take-home' messages for reducing risk in patients with elevated LDL-C.
No Credit Available
LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: EMERGING INSIGHTS
April 08, 2017
In this program, Dr. Lynn Braun and Dr. Michael Miller present lectures and case studies addressing the management of atherosclerotic cardiovascular disease along with best practices and treatment options.
No Credit Available
Optimizing Management of Recurrent Angina after PCI
May 08, 2015
Deepak Bhatt, MD, MPH, FSCAI (Chair); Duane Pinto, MD, FSCAI and Peter Stone, MD, MPH conduct a state-of-the-art discussion and case study on recurrent angina after PCI
No Credit Available
The Dynamics of In-Hospital and Post-Discharge ACS Management with Oral Antiplatelet Therapies
March 14, 2015
Jeffrey Anderson, MD, Van de Werf,MD and Marc Sabatine MD, discuss timing/location, dosing, duration of oral antiplatelet therapies, clinical trials, and guidelines.
No Credit Available
Oral Antiplatelet Therapies for Acute Coronary Syndromes: State of the Art Management
September 15, 2014
Deepak Bhatt, MD, MPH (Chair), Paul Gurbel, MD, Robert Harrington, MD, Ajay Kirtane, MD, SM, Manesh Patel, MD, Marc Sabatine, MD, MPH and Philippe Gabriel Steg, MD discuss contemporary use of antiplatelet therapy and ACS management in lectures and cases.
No Credit Available
The Acute Coronary Syndrome Patient: Surveying the Landscape of Antiplatelet Therapy and Best Practices in Secondary Prevention
August 18, 2014
Gregg W. Stone, MD (Chair);Jeffrey S. Berger, MD, MS and Jessica L. Mega, MD, MPH lead discussions on Surveying the landscape of antiplatelet therapy and best practices in secondary prevention
No Credit Available
From Clinical Trials to Clinical Practice: Optimizing Outcomes with Oral Antiplatelet Therapies in Acute Coronary Syndromes
March 30, 2014
This presentation was filmed as a Roundtable discussion and chaired by Christopher Cannon, MD. The expert panel included Deepak Bhatt, MD, MPH, James De Lemos, MD, and Roxana Mehran, MD
No Credit Available